NovoCure (N2VC34.SA) Q4 2024 Earnings

30OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-2.59
-2.26
-1.94
-1.61

Details

Expected EPS
-1.9234557399999999
Actual EPS
-1.613444
Surprise EPS
0.31
Surprise Percent
+16.12%

Description

NovoCure (N2VC34.SA) has reported earnings of -1.613444 per share for Q4 2024.

0 Comments

Share your thoughts